期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

TXA_2合成酶抑制剂和TXA_2受体拮抗剂的研究进展 被引量：13

Progress of TXSIs and TXA_2 Receptor Antagonists
下载PDF
导出
摘要 血栓素花生四烯酸 (TXA2 )是花生四烯酸代谢过程中的一个重要产物。现已发现 ,某些心血管疾病与TXA2 的过量产生有关。因此对 TXA2 合成酶抑制剂和 TXA2 受体拮抗剂的研究成为近年来的热点之一。 Thromboxane A 2(TXA 2) is a kind of bio metabolite of Arachidonic acid. It has been found that some serious diseases of the blood vessels of the heart and brain were related with oversupply of TXA 2. It has become an important development field to research TXSIs and TXA\-2 receptor antagonists. In this paper, the kind of medicines on market and some new findings were reviewed.
作者 刘秀杰 方林 程卯生
机构地区 沈阳药科大学制药工程学院
出处 《药学进展》 CAS 2002年第3期143-146,共4页 Progress in Pharmaceutical Sciences
关键词 TXA2合成酶抑制剂 TXA2受体拮抗剂 研究进展 Thromboxane synthase inhibitor TXA\-2 receptor antagonists Arachidonic acid
分类号 R969 [医药卫生—药理学]
  • 相关文献

参考文献20

  • 1[1]D L Cruz, P Jose, M Antonio,et al.Effect of DT-XT30, a combin e d thromboxane synthase inhibitor ang thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus[J]. Thrombosis Res,2000,97( 3):125-131.
  • 2[2]Francoise S L,Philippe D,Pierrick B,et al.Angiotensin Ⅱ-induced c ontractions in human internal mammary artery:effects of cyclooxygenase and lipox ygenase inhibition[J]. Cardiovascular Res,2000,47(2):376-383.
  • 3[3]Kawano K,Hokamura K,Komdo K,et al. Thromboxane A2 synthase inhib itor enhanced antithrombotic efficacy of GP Ⅱb-Ⅲa receptor antagonist with increasing bleeding[J]. Eur J Pharm, 2001,417(3):217-222.
  • 4[4]Ohyama H,Hosomi N,Takahashi T,et al. Thrombin inhibition attenuates n eurodegeneration and cerebral edema formation following transient forebrain isc hemia[J]. Brain Res, 2001,902(2):264-271.
  • 5[5]Takami M,Tsukada W.Effect of DP-1904,a thromboxane synthetase inhibi tor, on antigen-and spasmogen-induced bronchoconstriction in rodents[J]. Eur J Pharmacol,1999,366(2-3):253-259.
  • 6[6]Kato K, Ohkawa S, Terao S, et al. Thromboxane synthase inhibitors [J].J Med Chem,1985,28:287-294.
  • 7[7]Fiddler G,Lumley P.Preliminary clinical studies with thromboxane synt hase inhibitors and thromboxane receptor blockers[J]. Circulation,1990,81: 69-79.
  • 8[8]Okada S,Murakami Y,Nishihara M,et al. Perfusion of the hypothalamic p a raventricular nucleus with N-methyl-d-aspartate produces thromboxane A2 and centrally activates adrenomedullary outflow in rats[J]. Neuroscience,2000 ,96(3):585-590.
  • 9[9]Wouters J,Durant F,Masereel B.Antagonism of the TXA2 receptor by se ratrodast:a structural approach[J]. Bioorganic Med CHem Let,1999,9(19):286 7-2870.
  • 10[10]Sakariassen K S,Hanson S R,Cadroy Y.Methods and models to eval uate shear-dependent and surface reactivity-dependent antithrombotic efficacy [J]. Thrombosis Res,2001,104(3):149-174.

同被引文献113

引证文献13

二级引证文献96

药学进展
2002年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部